PMC:7299399 / 10026-10794
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T44 | 167-185 | Body_part | denotes | respiratory system | http://purl.org/sig/ont/fma/fma7158 |
| T45 | 448-455 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T13 | 167-185 | Body_part | denotes | respiratory system | http://purl.obolibrary.org/obo/UBERON_0001004 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T51 | 44-52 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T52 | 149-157 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T53 | 666-674 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T54 | 677-686 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T55 | 731-740 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T103 | 167-185 | http://purl.obolibrary.org/obo/UBERON_0001004 | denotes | respiratory system |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T42 | 231-236 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T43 | 360-373 | Chemical | denotes | nanoparticles | http://purl.obolibrary.org/obo/CHEBI_50803 |
| T44 | 375-378 | Chemical | denotes | NPs | http://purl.obolibrary.org/obo/CHEBI_50803 |
| T45 | 388-399 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T46 | 448-455 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T47 | 558-561 | Chemical | denotes | NPs | http://purl.obolibrary.org/obo/CHEBI_50803 |
| T48 | 742-745 | Chemical | denotes | PDT | http://purl.obolibrary.org/obo/CHEBI_53228|http://purl.obolibrary.org/obo/CHEBI_60622 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 708-723 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T45 | 54-186 | Sentence | denotes | Integrating nanomaterials into personal protective equipment (PPE) can prevent the entrance of SARS-CoV-2 in the respiratory system. |
| T46 | 187-276 | Sentence | denotes | Nanomaterials could also be used to deliver drugs to the pulmonary system via inhalators. |
| T47 | 277-456 | Sentence | denotes | Cellular binding of viral particles at the alveoli can be inhibited using targeted nanoparticles (NPs) against angiotensin-converting enzyme 2 (ACE2) receptors or viral S protein. |
| T48 | 457-594 | Sentence | denotes | Various mechanisms can be used to inactivate viral particles systemically such as using neutralizing NPs or photocatalytic nanomaterials. |
| T49 | 595-741 | Sentence | denotes | Nanomaterial-based vaccines or immunomodulation can be used to prevent SARS-CoV-2 infection or even to boost the immune response during infection. |
| T50 | 742-768 | Sentence | denotes | PDT, photodynamic therapy. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 185 | 388-419 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
| 186 | 421-425 | Gene | denotes | ACE2 | Gene:59272 |
| 187 | 149-159 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 188 | 167-178 | Species | denotes | respiratory | Tax:12814 |
| 189 | 44-52 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 190 | 671-686 | Disease | denotes | CoV-2 infection | MESH:C000657245 |
| 191 | 731-740 | Disease | denotes | infection | MESH:D007239 |